KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.88 Friday, 26th Apr 2024 PTN stock ended at $1.82. This is 5.81% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.93% from a day low at $1.68 to a day high of $1.83.
90 days $1.47 $5.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Aug 16, 2023 $2.48 $2.56 $2.43 $2.45 45 441
Aug 15, 2023 $2.78 $2.80 $2.46 $2.51 69 983
Aug 14, 2023 $2.80 $2.98 $2.77 $2.81 147 302
Aug 11, 2023 $2.76 $2.82 $2.58 $2.77 106 258
Aug 10, 2023 $2.90 $2.98 $2.62 $2.75 196 128
Aug 09, 2023 $2.68 $3.27 $2.68 $2.91 477 542
Aug 08, 2023 $2.50 $2.80 $2.40 $2.64 389 301
Aug 07, 2023 $2.13 $2.70 $2.08 $2.44 714 416
Aug 04, 2023 $2.00 $2.02 $1.96 $1.97 26 324
Aug 03, 2023 $2.02 $2.08 $2.00 $2.00 18 109
Aug 02, 2023 $2.20 $2.20 $2.03 $2.04 45 357
Aug 01, 2023 $2.16 $2.15 $2.09 $2.14 18 920
Jul 31, 2023 $1.89 $2.20 $1.94 $2.14 57 946
Jul 28, 2023 $1.87 $1.95 $1.89 $1.91 38 695
Jul 27, 2023 $2.02 $2.04 $1.82 $1.84 103 503
Jul 26, 2023 $1.96 $2.04 $1.97 $2.03 30 846
Jul 25, 2023 $1.95 $2.03 $1.95 $1.97 45 019
Jul 24, 2023 $2.03 $2.04 $1.95 $2.00 52 446
Jul 21, 2023 $2.05 $2.12 $1.91 $2.05 184 808
Jul 20, 2023 $2.19 $2.39 $1.99 $2.04 143 737
Jul 19, 2023 $2.15 $2.20 $2.15 $2.20 18 297
Jul 18, 2023 $2.14 $2.20 $2.14 $2.19 23 593
Jul 17, 2023 $2.13 $2.24 $2.13 $2.18 21 419
Jul 14, 2023 $2.18 $2.24 $2.15 $2.19 24 221
Jul 13, 2023 $2.23 $2.25 $2.14 $2.20 94 796
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT